Rhino Financial Statements From 2010 to 2026
| RBRXFDelisted Stock | USD 0.0001 0.00 0.00% |
Check Rhino Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rhino Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Rhino financial statements analysis is a perfect complement when working with Rhino Biotech Valuation or Volatility modules.
Rhino |
Rhino Biotech Limited Company Return On Asset Analysis
Rhino Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Rhino Biotech Return On Asset | -9.12 |
Most of Rhino Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rhino Biotech Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Rhino Biotech Limited has a Return On Asset of -9.121. This is much higher than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on asset for all United States stocks is notably higher than that of the company.
Rhino Biotech Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rhino Biotech's current stock value. Our valuation model uses many indicators to compare Rhino Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rhino Biotech competition to find correlations between indicators driving Rhino Biotech's intrinsic value. More Info.Rhino Biotech Limited is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rhino Biotech's earnings, one of the primary drivers of an investment's value.About Rhino Biotech Financial Statements
Rhino Biotech stakeholders use historical fundamental indicators, such as Rhino Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rhino Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rhino Biotech's assets and liabilities are reflected in the revenues and expenses on Rhino Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rhino Biotech Limited. Please read more on our technical analysis and fundamental analysis pages.
Rhino Biotech Limited intends to develop plant and fungi derived nutraceuticals, and preventative and curative biopharmaceuticals. Rhino Biotech Limited was incorporated in 2003 and is based in South Hill, Anguilla. Rhino Biotech is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Rhino Pink Sheet
If you are still planning to invest in Rhino Biotech Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rhino Biotech's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |